Drugs / SII-YFV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05421611 | May 2023 → May 2024 | yellow fever | Serum Institute of India Pvt. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SII-YFV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05421611 ↗ |
| Modality | Vaccine | “It is a live, attenuated, freeze-dried (lyophilized) vaccine and is to be reconstituted with sterile water for injection.” NCT05421611 ↗ |